Inventor · disambiguated record
David Lawrence Cutler
Also filed as: CUTLER DAVID · CUTLER DAVID L · CUTLER DAVID LAWRENCE
12 granted patents·7 pending applications·666 citations·filing 1997–2022
93Inventor score
Top patents by PatentIndex Score
19 records- 0196US5908621APolyethylene glycol modified interferon therapySCHERING CORP·Filed 1997·Granted Jun 1, 1999·218 cites·4 claims
- 0295US6177074B1Polyethylene glycol modified interferon therapySCHERING CORP·Filed 1999·Granted Jan 23, 2001·161 cites·4 claims
- 0394US6461605B1Continuous low-dose cytokine infusion therapySCHERING CORP·Filed 2002·Granted Oct 8, 2002·87 cites·14 claims
- 0493US6524570B1Polyethylene glycol modified interferon therapySCHERING CORP·Filed 2000·Granted Feb 25, 2003·53 cites·36 claims
- 0590US10617693B2Methods of treating and/or preventing actinic keratosisATHENEX INC·Filed 2018·Granted Apr 14, 2020·6 cites·25 claims
- 0689US6096757AMethod for treating proliferative diseasesSCHERING CORP·Filed 1998·Granted Aug 1, 2000·91 cites·21 claims
- 0787US11497750B2Methods of treating and/or preventing actinic keratosisATHENEX INC·Filed 2020·Granted Nov 15, 2022·2 cites·23 claims
- 0886US6333333B1Methods for treating proliferative diseasesSCHERING CORP·Filed 2000·Granted Dec 25, 2001·22 cites·24 claims
- 0985US10849893B2Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2019·Granted Dec 1, 2020·2 cites·32 claims
- 1082US11389442B2Therapeutic combinations of orally administered docetaxel and a P-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2020·Granted Jul 19, 2022·1 cites·19 claims
- 1170US2023046869A1Therapeutic combinations of orally administered docetaxel and a p-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2022·Application pending·0 cites
- 1265US2023172942A1Methods of treating and/or preventing actinic keratosisATNX SPV LLC·Filed 2022·Application pending·0 cites
- 1361US5945097AMethod for lowering cholesterol levels with interleukin-10SCHERING CORP·Filed 1997·Granted Aug 31, 1999·23 cites·27 claims
- 1461US2024390360A1Therapeutic Combinations Of Orally Administered Paclitaxel, A P-gp Inhibitor, And A Checkpoint Inhibitor For The Treatment Of Solid TumorsATHENEX INC·Filed 2022·Application pending·0 cites
- 1556US11752139B2Therapeutic combinations of orally administered irinotecan and a p-gp inhibitor for the treatment of cancerATHENEX HK INNOVATIVE LTD·Filed 2019·Granted Sep 12, 2023·0 cites·16 claims
- 1648US2004006087A1Method of treating cancer using FPT inhibitors and antineoplastic agentsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1745US2006183765A1Methods of treating cancer using an FPT inhibitor and antineoplastic agentsCUTLER DAVID L·Filed 2006·Application pending·0 cites
- 1844US2003185831A1Methods of treating cancer using an FPT inhibitor and antineoplasticSCHERING CORP·Filed 2002·Application pending·0 cites
- 1943US2006122162A1Methods of using temozolomide formulation intrathecally in the treatment of cancersSCHERING CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Lawrence Cutler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →